Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(40.0%)
Early Phase 1
1(20.0%)
Phase 1
1(20.0%)
N/A
1(20.0%)
5Total
Phase 2(2)
Early Phase 1(1)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02385357Early Phase 1Unknown

Effect of a Protein-enriched Drink on Muscle Function

Role: lead

NCT01947426Phase 2Completed

Effect of Mother DHA Supplementation on Term Newborn.

Role: collaborator

NCT01346644Not ApplicableCompleted

Safety of Lactobacillus Fermentum in Newborn Infants

Role: lead

NCT01215656Phase 2Completed

Effect of a Follow on Formula With Lactobacillus Fermentum on the Incidence of Infections

Role: lead

NCT00724204Phase 1Completed

Safety Assessment of Lactobacillus Salivarius CECT5713 in 6 Months Old Children

Role: lead

All 5 trials loaded